Cargando…
Early life administration of Bifidobacterium bifidum BD-1 alleviates long-term colitis by remodeling the gut microbiota and promoting intestinal barrier development
Inflammatory bowel disease (IBD) is a chronic intestinal disease characterized by microbiota disturbance and intestinal mucosal damage. The current study aimed to investigate the preventive effects of Bifidobacterium bifidum BD-1 (BD-1) against long-term IBD and possible mechanism by which it alters...
Autores principales: | Peng, Chenrui, Li, Jinxing, Miao, Zhonghua, Wang, Yunyi, Wu, Simou, Wang, Yimei, Wang, Silu, Cheng, Ruyue, He, Fang, Shen, Xi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355606/ https://www.ncbi.nlm.nih.gov/pubmed/35935215 http://dx.doi.org/10.3389/fmicb.2022.916824 |
Ejemplares similares
-
Maternal gestational Bifidobacterium bifidum TMC3115 treatment shapes construction of offspring gut microbiota and development of immune system and induces immune tolerance to food allergen
por: Cheng, Ruyue, et al.
Publicado: (2022) -
Bifidobacterium bifidum PRL2010 alleviates intestinal ischemia/reperfusion injury
por: Duranti, Sabrina, et al.
Publicado: (2018) -
Bifidobacterium bifidum CCFM1163 Alleviated Cathartic Colon by Regulating the Intestinal Barrier and Restoring Enteric Nerves
por: Tang, Nan, et al.
Publicado: (2023) -
Safety Evaluations of Bifidobacterium bifidum BGN4 and Bifidobacterium longum BORI
por: Kim, Min Jeong, et al.
Publicado: (2018) -
Bifidobacterium bifidum-Mediated Specific Delivery of Nanoparticles for Tumor Therapy
por: Tang, Yu, et al.
Publicado: (2021)